Status: current, Defined. Date: 31-Jul 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2004521000168119 | canakinumab 150 mg injection [4 x 150 mg vials] (&) inert substance diluent [4 vials], 1 pack (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2004531000168116 | canakinumab 150 mg injection [4 vials] (&) inert substance diluent [4 vials], 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| canakinumab 150 mg injection [4 x 150 mg vials] (&) inert substance diluent [4 vials], 1 pack (medicinal product pack) | Is a | canakinumab 150 mg injection, 4 vials | true | Inferred relationship | Some | ||
| canakinumab 150 mg injection [4 x 150 mg vials] (&) inert substance diluent [4 vials], 1 pack (medicinal product pack) | has MPUU | inert substance diluent, vial | true | Inferred relationship | Some | 1 | |
| canakinumab 150 mg injection [4 x 150 mg vials] (&) inert substance diluent [4 vials], 1 pack (medicinal product pack) | has MPUU | canakinumab 150 mg injection, vial | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ilaris (4 x 150 mg vials, 4 x inert diluent vials), 1 pack | Is a | True | canakinumab 150 mg injection [4 x 150 mg vials] (&) inert substance diluent [4 vials], 1 pack (medicinal product pack) | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR